| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.8M | +257.7% |
| R&D Expense | $102.1M | +16.3% |
| SG&A Expense | $32.1M | +15.6% |
| Operating Income | -$63.4M | +33.8% |
| Pre-tax Income | -$59.0M | +38.3% |
| Income Tax | $67K | — |
| Net Income | -$59.0M | +38.2% |
| EPS (Basic) | -$1.55 | +41.9% |
| EPS (Diluted) | -$1.55 | +41.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.3M | -65.4% |
| Accounts Receivable | $455K | -80.3% |
| Current Assets | $362.2M | -13.4% |
| Total Assets | $368.6M | -13.5% |
| Current Liabilities | $17.1M | -55.2% |
| Total Liabilities | $19.5M | -78.3% |
| Stockholders' Equity | $349.1M | +3.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$101.0M | -21.0% |
| Capital Expenditures | $365K | -64.2% |
| Investing Cash Flow | -$56.5M | +50.1% |
| Financing Cash Flow | $45.3M | -83.0% |
| Free Cash Flow | -$101.3M | -20.0% |